Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Polyomavirus BK infection in blood and marrow transplant recipients

Bone Marrow Transplantation volume 41, pages 11–18 (2008)Cite this article

Abstract

The association of BK virus infection with hemorrhagic cystitis in blood and marrow transplant (BMT) recipients was first demonstrated two decades ago. During this time, therapeutic interventions focused on supportive measures such as hyperhydration, continuous bladder irrigation and topical administration of agents that alter the mucosal surface of the bladder wall. In recent years, PCR amplification of viral DNA in the urine and plasma has solidified the association of BK virus infection with hemorrhagic cystitis, demonstrating that higher urine and plasma viral loads occur in the setting of disease. The evaluation of virus-specific therapy has lagged behind assessment of the viral load and theories of pathogenesis. Extrapolating from successes in the treatment of BK virus nephropathy in the renal transplant population, cidofovir and leflunomide are identified as potential effective agents for the treatment of BK virus-associated hemorrhagic cystitis. The fluoroquinolone antibiotics may prove to be effective as prophylactic agents. Given the manifestation of BK virus infection in organs outside of the urinary tract in an increasing immunocompromised patient population and the availability of potential antiviral agents, therapeutic trials need to progress beyond the small case series in order to improve the morbidity and mortality caused by BK virus-associated hemorrhagic cystitis in the BMT population.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Gardner SD, Field AM, Coleman DV, Hulme B . New papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1971; 1: 253–257.

    Google Scholar 

  2. Arthur RR, Shah KV, Baust SJ, Santos GW, Saral R . Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med 1986; 315: 230–234.

    CAS  PubMed  Google Scholar 

  3. Arthur RR, Shah KV, Charache P, Saral R . BK and JC virus infections in recipients of bone marrow transplants. J Infect Dis 1988; 158: 563–569.

    CAS  PubMed  Google Scholar 

  4. Apperley JF, Rice SJ, Bishop JA, Chia YC, Krausz T, Gardner SD et al. Late-onset hemorrhagic cystitis associated with urinary excretion of polyomaviruses after bone marrow transplantation. Transplantation 1987; 43: 108.

    CAS  PubMed  Google Scholar 

  5. Pappo O, Demetris AJ, Raikow RB, Randhawa PS . Human polyoma virus infection of renal allografts: histopathologic diagnosis, clinical significance, and literature review. Mod Pathol 1996; 9: 105–109.

    CAS  PubMed  Google Scholar 

  6. Randhawa PS, Demetris AJ . Nephropathy due to polyomavirus type BK. N Engl J Med 2000; 342: 1361–1363.

    CAS  PubMed  Google Scholar 

  7. Hirsch HH, Steiger J . Polyomavirus BK. Lancet Infect Dis 2003; 3: 611–623.

    PubMed  Google Scholar 

  8. Khalili K, Gordon J, White MK . The polyomavirus, JCV and its involvement in human disease. Adv Exp Med Biol 2006; 577: 274–287.

    CAS  PubMed  Google Scholar 

  9. Yousry TA, Major EO, Ryschkewitsch C, Fahle G, Fischer S, Hou J et al. Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med 2006; 354: 924–933.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Steurer M, Clausen J, Gotwald T, Gunsilius E, Stockhammer G, Gastl G et al. Progressive multifocal encephalopathy after allogeneic stem cell transplantation and posttransplantation rituximab. Transplantation 2003; 76: 435–436.

    PubMed  Google Scholar 

  11. Milstone A, Vilchez RA, Geiger X, Fogo AB, Butel JS, Dummer S . Polyomavirus simian virus 40 infection associated with nephropathy in lung-transplant recipient. Transplantation 2004; 77: 1019–1024.

    PubMed  Google Scholar 

  12. Li RM, Branton MH, Tanawattanacharoen S, Falk RA, Jennette JC, Kopp JB . Molecular identification of SV40 infection in human subjects and possible association with kidney disease. J Am Soc Nephrol 2002; 13: 2320–2330.

    CAS  PubMed  Google Scholar 

  13. Goudsmit J, Wertheim-van Dillen P, van Strien A, van der NJ . The role of BK virus in acute respiratory tract disease and the presence of BK virus DNA in tonsils. J Med Virol 1982; 10: 91–99.

    CAS  PubMed  Google Scholar 

  14. Reploeg MD, Storch GA, Clifford DB . BK virus: a clinical review. Clin Infect Dis 2001; 33: 191–202.

    CAS  PubMed  Google Scholar 

  15. Coleman DV, Gardner SD, Mulholland C, Fridiksdottir V, Porter AA, Lilford R et al. Human polyomavirus in pregnancy a model for the study of defense mechanisms to virus reactivation. Clin Exp Immunol 1983; 53: 289–296.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Kitumura T, Aso Y, Kuniyoshi N, Hara K, Yogo Y . High incidence of urinary JC virus excretion in nonimmunosuppressed older patients. J Infect Dis 1990; 161: 1128–1133.

    Google Scholar 

  17. Behzad-Behbahani A, Klapper PE, Vallely PJ, Cleator GM, Khoo SH . Detection of BK virus and JC virus DNA in urine samples in immunocompromised (HIV-infected) and immunocompetent (HIV-non-infected) patients using polymerase chain reaction and microplate hybridization. J Clin Virol 2004; 29: 224–229.

    CAS  PubMed  Google Scholar 

  18. Munoz P, Fogeda M, Bouza E, Verde E, Palomo J, Banares R . Prevalence of BK virus replication among recipients of solid organ transplants. Clin Infect Dis 2005; 41: 1720–1725.

    PubMed  Google Scholar 

  19. Bedi A, Miller CB, Hanson JL, Goodman S, Ambinder RF, Charache P et al. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol 1995; 13: 1103–1109.

    CAS  PubMed  Google Scholar 

  20. Azzi A, Cesaro S, Laszlo D, Zakrzewska K, Ciappi S, De Santis R et al. Human polyomavirus BK (BKV) load and hemorrhagic cystitis in bone marrow transplant patients. J Clin Virol 1999; 14: 79–86.

    CAS  PubMed  Google Scholar 

  21. Anderson EE, Cobb OE, Glenn JF . Cyclophosphamide hemorrhagic cystitis. J Urol 1967; 97: 857–858.

    CAS  PubMed  Google Scholar 

  22. Cox PJ . Cyclophosphamide cystitis—identification of acrolein as the causative agent. Biochem Pharmacol 1979; 28: 2045–2049.

    CAS  PubMed  Google Scholar 

  23. Droller MJ, Saral R, Santos G . Prevention of cyclophosphamide-induced hemorrhagic cystitis. Urology 1982; 20: 256–258.

    CAS  PubMed  Google Scholar 

  24. Leung AYH, Seun CKM, Lie AKW, Liang RHS, Yuen KY, Kwong YL . Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation. Blood 2001; 98: 1971–1978.

    CAS  PubMed  Google Scholar 

  25. Wong SY, Chan K-H, Cheng VCC, Yuen K-Y, Kwong Y-L, Leung AYH . Relationship of pretransplantation polyoma BK virus serologic findings and BK viral reactivation after hematopoietic stem cell transplantation. Clin Infect Dis 2007; 44: 830–837.

    PubMed  Google Scholar 

  26. Bogdanovic G, Priftakis P, Giraud G, Kuzniar M, Ferraldeschi R, Kokhaei P et al. Association between a high BK virus load in urine samples of patients with graft-versus-host disease and development of hemorrhagic cystitis after hematopoietic stem cell transplantation. J Clin Microbiol 2004; 42: 5394–5396.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Nickeleit V, Klimkait T, Binet IF, Dalquen P, Del Zenero V, Thiel G et al. Testing for polyomavirus type BK DNA in plasma to identify renal allograft recipients with viral nephropathy. N Engl J Med 2000; 342: 1309–1315.

    CAS  PubMed  Google Scholar 

  28. Erard V, Kim HW, Corey L, Limaye A, Huang M-L, Myerson D et al. BK DNA viral load in plasma: evidence for an association with hemorrhagic cystitis in allogeneic hematopoietic cell transplant recipients. Blood 2005; 106: 1130–1132.

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Leung AYH, Mak R, Lie AKW, Yuen KY, Cheng VCC, Liang R et al. Clinicopathological features and risk factors of clinically overt hemorrhagic cystitis complicating bone marrow transplantation. Bone Marrow Transplant 2002; 29: 509–513.

    CAS  PubMed  Google Scholar 

  30. Leung AYH, Chan M, Cheng VCC, Lie AKW, Yuen K-Y, Kwong Y-L . Polyoma BK viruria in patients undergoing autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 2005; 35: 1029–1030.

    CAS  PubMed  Google Scholar 

  31. Seber A, Shu XO, Defor T, Sencer T, Ramsay N . Risk factors for severe hemorrhagic cystitis following BMT. Bone Marrow Transplant 1999; 23: 35–40.

    CAS  PubMed  Google Scholar 

  32. Binet I, Nickeleit V, Hirsch HH . Polyomavirus infections in transplant recipients. Curr Opin Organ Transplant 2000; 5: 210–216.

    Google Scholar 

  33. Cheng VCC, Yuen K-Y, Chan W-M, Wong SSY, Edmond SKM, Chan RMT . Immune reconstitution disease involving the innate and adaptive responses. Clin Infect Dis 2000; 30: 882–892.

    CAS  PubMed  Google Scholar 

  34. Safdar A, Rubocki RJ, Horvath JA, Narayan KK, Waldron RL . Fatal immune restoration disease in human immunodeficiency virus type-1 infected patients with progressive multifocal leukoencephalopathy: impact of antiretroviral therapy-associated immune reconstitution. Clin Infect Dis 2002; 35: 1250–1257.

    PubMed  Google Scholar 

  35. D’Amico R, Sarkar S, Yusuff J, Azar E, Perlman DC . Immune reconstitution after potent antiretroviral therapy in AIDS patients with progressive mutifocal leukoencephalopathy. Scand J Infect Dis 2007; 39: 347–350.

    PubMed  Google Scholar 

  36. Leung AYH, Yuen K-Y, Kwong Y-L . Polyoma BK virus and haemorrhagic cystitis in haematopoietic stem cell transplantation: a changing paradigm. Bone Marrow Transplant 2005; 36: 929–937.

    CAS  PubMed  Google Scholar 

  37. Fogazzi GB, Cantu M, Saglimbeni L . Decoy cells in the urine due to polyomavirus BK infection: easily seen by phase contrast microscopy. Nephrol Dial Transplant 2001; 16: 1496–1498.

    CAS  PubMed  Google Scholar 

  38. Ambinder RF, Burns W, Forman M, Charache P, Arthur R, Beschorner W et al. Hemorrhagic cystitis associated with adenovirus infection in bone marrow transplantation. Arch Int Med 1986; 146: 1400–1401.

    CAS  Google Scholar 

  39. Akiyama H, Kurosu T, Sakashita C, Inoue T . Adenovirus is a key pathogen in hemorrhagic cystitis associated with bone marrow transplantation. Clin Infect Dis 2001; 32: 1325.

    CAS  PubMed  Google Scholar 

  40. Spach DH, Bauwens JE, Myerson D, Mustafa MM, Bowden RA . Cytomegalovirus-induced hemorrhagic cystitis following bone marrow transplantation. Clin Infect Dis 1993; 16: 142–144.

    CAS  PubMed  Google Scholar 

  41. Sebe P, Garderet L, Traxer O, Nouri M, Gluckman E, Gattegno B . Subtotal cytectomy with ileocystoplasty for severe hemorrhagic cystitis after bone marrow transplantation. Urology 2001; 57l: 168xiv–168xvi.

    Google Scholar 

  42. Gorczynska E, Turkiewicz D, Rybka K, Toporski J, Kalwak K, Dyla A et al. Incidence, clinical outcome, and management of virus-induced hemorrhagic cystitis in children and adolescents after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2005; 11: 797–804.

    PubMed  Google Scholar 

  43. De Clercq E, Holy A . Acyclic nucleoside phosphonates: a key class of antiviral drugs. Nat Rev Drug Discov 2005; 4: 928–940.

    CAS  PubMed  Google Scholar 

  44. Dunn JP, Van Natta M, Foster G, Kuppermann BD, Martin DF, Zong A et al. Complications of ganciclovir implant surgery in patients with cytomegalovirus retinitis: the ganciclovir cidifovir cytomegalovirus retinitis trial. Retina 2004; 24: 41–50.

    PubMed  Google Scholar 

  45. Preiksaitis JK, Brennan DC, Fishman J, Allen U . Canadian society of transplantation consensus workshop of cytomegalovirus management in solid organ transplantation final report. Am J Transplant 2005; 5: 218–227.

    PubMed  Google Scholar 

  46. Randhawa P, Farasati NA, Shapiro R, Hostetler KY . Ether lipid ester derivatives of cidofovir inhibit polyomavirus BK replication in vitro. Antimicrob Agents Chemother 2006; 50: 1564–1566.

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Josephson MA, Williams JW, Chandraker A, Randhawa PS . Polyomavirus-associated nephropathy: update on antiviral strategies. Transpl Infect Dis 2006; 8: 95–101.

    CAS  PubMed  Google Scholar 

  48. Farasati NA, Shapiro R, Vats A, Randhawa P . Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system. Transplantation 2005; 79: 116–118.

    CAS  PubMed  Google Scholar 

  49. Vats A, Shapiro R, Randhawa SP, Scantlebury V, Tuzuner A, Saxena M et al. Quantitative viral load monitoring and cidofovir therapy for management of BK virus-associated nephropathy in children and adults. Transplantation 2003; 75: 105–112.

    CAS  PubMed  Google Scholar 

  50. Kadambi PV, Josephson MA, Williams J, Corey L, Jerome KR, Meehan SM et al. Treatment of refractory BK virus-associated nephropathy with cidofovir. Am J Transplant 2003; 3: 186–191.

    PubMed  Google Scholar 

  51. Held TK, Biel SS, Nitsche A, Kurth A, Chen S, Gelderblom HR et al. Treatment of BK virus-associated hemorrhagic cystitis and simultaneous CMV reactivation with cidofovir. Bone Marrow Transplant 2000; 26: 347–350.

    CAS  PubMed  Google Scholar 

  52. Savona MR, Newton D, Frame D, Levine JE, Mineishi S, Kaul DR . Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant. Bone Marrow Transplant 2007; 39: 783–787.

    CAS  PubMed  Google Scholar 

  53. Bridges B, Donegan S, Badros A . Cidofovir bladder instillation for the treatment of BK hemorrhagic cystitis after allogeneic stem cell transplantation. Am J Hematol 2006; 81: 531–537.

    Google Scholar 

  54. Strand V, Cohen S, Schiff M, Weaver A, Fleischmann R, Cannon G et al. Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Arch Intern Med 1999; 159: 2542–2550.

    CAS  PubMed  Google Scholar 

  55. Rinaldo CH, Hirsch HH . Antivirals for the treatment of polyomavirus BK replication. Expert Rev Anti Infect Ther 2007; 5: 105–115.

    CAS  PubMed  Google Scholar 

  56. Waldman WJ, Knight DA, Blinder L, Shen J, Lurain NS, Miller DM et al. Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide. Intervirology 1999; 42: 412–418.

    CAS  PubMed  Google Scholar 

  57. Williams JW, Javaid B, Kadambi PV, Gillen D, Harland R, Thistlewaite JR et al. Leflunomide for polyomavirus type BK nephropathy. N Engl J Med 2005; 352: 1157–1158.

    CAS  PubMed  Google Scholar 

  58. Josephson MA, Gillen MA, Javaid B, Kadambi P, Meehan S, Foster P et al. Treatment of renal allograft polyoma BK virus infection with leflunomide. Transplantation 2006; 81: 704–710.

    CAS  PubMed  Google Scholar 

  59. Avery RK, Bolwell BJ, Yen-Lieberman B, Lurain N, Waldman WJ, Longworth DL et al. Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection. Bone Marrow Transplant 2004; 34: 1071–1075.

    CAS  PubMed  Google Scholar 

  60. Battiwalla M, Paplham P, Almyroudis NG, McCarthy A, Abdelhalim A, Elefante A et al. Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation. Transpl Infect Dis 2007; 9: 28–32.

    CAS  PubMed  Google Scholar 

  61. Ferrazzi E, Peracchi M, Biasolo MA, Faggionato O, Stefanelli S, Palu G et al. Antiviral activity of gyrase inhibitors norfloxacin, coumermycin A1, and nalidixic acid. Biochem. Pharmacol 1988; 37: 1885–1886.

    CAS  PubMed  Google Scholar 

  62. Portolani M, Pietrosemoli P, Cermelli C, Mannini-Palenzona A, Grossi MP, Paolini L et al. Suppression of BK virus replication and cytopathic effect by inhibitors of prokaryotic DNA gyrase. Antiviral Res 1988; 9: 205–218.

    CAS  PubMed  Google Scholar 

  63. Randhawa PS . Anti-BK virus activity of ciprofloxacin and related antibiotics. Clin Infect Dis 2005; 41: 1366–1367.

    PubMed  Google Scholar 

  64. Ali S, Chandraker A, DeCaprio J . Inhibition of polyoma helicase activity by quinolones. J Am Soc Neprhol 2003; 14: 43A.

    Google Scholar 

  65. Leung AY, Chan MT, Yuen KY, Cheng VC, Chan KH, Wong CL et al. Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2005; 40: 528–537.

    CAS  PubMed  Google Scholar 

  66. Chandraker A, Ali S, Drachenberg CB, Ravinder W, Hirsch H, DeCaprio J et al. Use of fluoroquinolones to treat BK infection in renal transplant recipients. Am J Transplant 2004; 4 (Suppl 8): 587.

    Google Scholar 

  67. Limaye AP, Smith KD, Cook L, Groom DA, Hunt NC, Jerome KR et al. Polyomavirus nephropathy in native kidneys of non-renal transplant recipients. Am J Transplant 2005; 5: 614–620.

    PubMed  Google Scholar 

  68. Shapiro S, Robin M, Esperou H, Rocha V, Garnier T, Gluckman E et al. Polyomavirus nephropathy in the native kidneys of an unrelated cord blood transplant recipient followed by a disseminated polyomavirus infection. Transplantation 2006; 82: 292–293.

    PubMed  Google Scholar 

  69. Avery RK . BK virus and renal dysfunction. Clin Infect Dis 2005; 41: 1726–1727.

    PubMed  Google Scholar 

  70. Stracke S, Helmchen U, von Muller L, Bunjes D, Keller F . Polyoma virus-associated interstitial nephritis in a patient with acute myeloid leukaemia and peripheral blood stem cell transplantation. Nephrol Dial Transplant 2003; 18: 2431–2433.

    PubMed  Google Scholar 

  71. Gaston K, Gabriel DA, Lavelle JP . Rare cause of ureteral obstruction. Urology 2005; 66: 1110.e5–1110.e6.

    Google Scholar 

  72. Stoner GL, Alappan R, Jobes DV, Ryschkewitsch CF, Landry Ml . BK virus regulatory rearrangements in brain and cerebrospinal fluid from a leukemia patient with tubulointerstitial nephritis and meningoencephalitis. Am J Kidney Dis 2002; 39: 1102–1112.

    CAS  PubMed  Google Scholar 

  73. Vago L, Cinque P, Sala E, Nebuloni M, Calderelli R, Racca S et al. JCV-DNA and BKV-DNA in the CNS tissue and CSF of AIDS patients and normal subjects. Study of 41 cases and review of the literature. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 12: 139–146.

    CAS  PubMed  Google Scholar 

  74. Vallbracht A, Lohler J, Gossmann J, Gluck T, Petersen D, Gerth HJ et al. Disseminated BK type polyomavirus infection in an AIDS patients associated with central nervous system disease. Am J Pathol 1993; 143: 29–39.

    CAS  PubMed  PubMed Central  Google Scholar 

  75. Jorgensen GE, Hammarin AL, Bratt G, Grandien M, Flaegstad T, Johnsen JI . Identification of a unique BK virus variant in the CNS of a patient with AIDS. J Med Virol 2003; 70: 14–19.

    CAS  PubMed  Google Scholar 

  76. Bratt G, Hammarin AL, Grandien M, Hedquist BG, Nennesmo I, Sundelin B et al. BK virus as the cause of meningoencephalitis, retinitis and nephritis in a patient with AIDS. AIDS 1999; 13: 1071–1075.

    CAS  PubMed  Google Scholar 

  77. Lesprit P, Chaline-Lehmann D, Authier FJ, Ponnelle T, Gray F, Levy Y . BK virus encephalitis in a patient with AIDS and lymphoma. AIDS 2001; 15: 1196–1199.

    CAS  PubMed  Google Scholar 

  78. Hedquist BG, Bratt G, Hammarin AL, Grandien M, Nennesmo I, Sundelin B et al. Identification of BK virus in a patient with acquired immune deficiency syndrome and bilateral atypical retinitis. Ophthalmology 1999; 106: 129–132.

    CAS  PubMed  Google Scholar 

  79. Agostini HT, Ryschkewitsch CF, Singer JE, Stoner GL . JC virus regulatory region rearrangments and genotypes in progressive multifocal leukoencephalopathy: two independent aspects of virus variation. J Gen Virol 1997; 78: 659–664.

    CAS  PubMed  Google Scholar 

  80. Sandler ES, Aquino VM, Goss-Shohet E, Hinrichs S, Krisher K . BK papova virus pneumonia following hematopoietic stem cell transplantation. Bone Marrow Transplant 1997; 20: 163–165.

    CAS  PubMed  PubMed Central  Google Scholar 

  81. Galan A, Rauch CA, Otis CN . Fatal BK polyoma viral pneumonia associated with immunosuppression. Hum Pathol 2005; 36: 1031–1034.

    CAS  PubMed  Google Scholar 

  82. Petrogiannis-Haliotis T, Sakoulas G, Kirby J, Koralnik IJ, Dvorak AM, Monahan-Earley R et al. BK-related polyomavirus vasculopathy in a renal transplant recipient. N Engl J Med 2001; 345: 1250–1255.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, MD, USA

    L K Dropulic

  2. Department of Oncology, Johns Hopkins Medical Institutions, Baltimore, MD, USA

    R J Jones

Authors
  1. L K Dropulic
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R J Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L K Dropulic.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dropulic, L., Jones, R. Polyomavirus BK infection in blood and marrow transplant recipients. Bone Marrow Transplant 41, 11–18 (2008). https://doi.org/10.1038/sj.bmt.1705886

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705886

Keywords

This article is cited by

Search

Advanced search

Quick links